Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 10
2003 8
2004 14
2005 16
2006 18
2007 22
2008 22
2009 15
2010 14
2011 16
2012 13
2013 10
2014 13
2015 12
2016 19
2017 18
2018 15
2019 11
2020 18
2021 22
2022 11
2023 6
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
Extracellular matrix-based cancer targeting.
Karamanos NK, Piperigkou Z, Passi A, Götte M, Rousselle P, Vlodavsky I. Karamanos NK, et al. Among authors: vlodavsky i. Trends Mol Med. 2021 Oct;27(10):1000-1013. doi: 10.1016/j.molmed.2021.07.009. Epub 2021 Aug 10. Trends Mol Med. 2021. PMID: 34389240 Review.
Heparanase Modulates Chromatin Accessibility.
Li H, Zhang H, Wenz A, Kang Z, Wang H, Vlodavsky I, Chen X, Li J. Li H, et al. Among authors: vlodavsky i. Cells. 2023 Mar 14;12(6):891. doi: 10.3390/cells12060891. Cells. 2023. PMID: 36980232 Free PMC article.
Heparanase-The Message Comes in Different Flavors.
Ilan N, Bhattacharya U, Barash U, Boyango I, Yanku Y, Gross-Cohen M, Vlodavsky I. Ilan N, et al. Among authors: vlodavsky i. Adv Exp Med Biol. 2020;1221:253-283. doi: 10.1007/978-3-030-34521-1_9. Adv Exp Med Biol. 2020. PMID: 32274713 Review.
Heparanase inhibitors restrain mesothelioma.
Lapidot M, Barash U, Vlodavsky I, Pass H. Lapidot M, et al. Among authors: vlodavsky i. Oncotarget. 2018 Dec 7;9(96):36830-36832. doi: 10.18632/oncotarget.26243. eCollection 2018 Dec 7. Oncotarget. 2018. PMID: 30627323 Free PMC article.
Heparanase: busy at the cell surface.
Fux L, Ilan N, Sanderson RD, Vlodavsky I. Fux L, et al. Among authors: vlodavsky i. Trends Biochem Sci. 2009 Oct;34(10):511-9. doi: 10.1016/j.tibs.2009.06.005. Epub 2009 Sep 3. Trends Biochem Sci. 2009. PMID: 19733083 Free PMC article. Review.
The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.
Ramani VC, Purushothaman A, Stewart MD, Thompson CA, Vlodavsky I, Au JL, Sanderson RD. Ramani VC, et al. Among authors: vlodavsky i. FEBS J. 2013 May;280(10):2294-306. doi: 10.1111/febs.12168. Epub 2013 Mar 4. FEBS J. 2013. PMID: 23374281 Free PMC article. Review.
289 results